Informações:
Falhas:
ID
18104
Descrição
A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome; ODM derived from: https://clinicaltrials.gov/show/NCT00170937
Link
https://clinicaltrials.gov/show/NCT00170937
Palavras-chave
Versões (1)
- 19/10/2016 19/10/2016 -
Transferido a
19 de outubro de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Metabolic Syndrome NCT00170937
Eligibility Metabolic Syndrome NCT00170937
- StudyEvent: Eligibility
Similar models
Eligibility Metabolic Syndrome NCT00170937
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Waist Circumference | Gender
Item
waist circumference: males > 40", females > 35 "
boolean
C0455829 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
C0079399 (UMLS CUI [2])
Sitting systolic blood pressure mean | Sitting diastolic blood pressure mean
Item
mssbp ≥ 130 mmhg but ≤ 160 mmhg and a msdbp ≥ 85 mmhg but ≤ 100 mmhg
boolean
C1319893 (UMLS CUI [1,1])
C0444504 (UMLS CUI [1,2])
C1319894 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C0444504 (UMLS CUI [1,2])
C1319894 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
Plasma fasting glucose measurement | Serum Triglyceride Measurement | Low density lipoprotein cholesterol measurement | Gender
Item
at least one of the following criteria: - fasting plasma glucose between 5.9 and 6.9 mmol/l; - serum triglycerides > 150 mg/dl; - ldl cholesterol: - < 40 mg/dl males; - < 50 mg/dl females
boolean
C0583513 (UMLS CUI [1])
C0542495 (UMLS CUI [2])
C0202117 (UMLS CUI [3])
C0079399 (UMLS CUI [4])
C0542495 (UMLS CUI [2])
C0202117 (UMLS CUI [3])
C0079399 (UMLS CUI [4])
Sitting systolic blood pressure mean | Sitting diastolic blood pressure mean
Item
mssbp> 180 mmhg or msdbp > 110 mmhg
boolean
C1319893 (UMLS CUI [1,1])
C0444504 (UMLS CUI [1,2])
C1319894 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C0444504 (UMLS CUI [1,2])
C1319894 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
Antihypertensive Agents Discontinue Time period Unable
Item
inability to discontinue all prior antihypertensives for a period of 4 weeks.
boolean
C0003364 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C1948053 (UMLS CUI [1,3])
C1299582 (UMLS CUI [1,4])
C1444662 (UMLS CUI [1,2])
C1948053 (UMLS CUI [1,3])
C1299582 (UMLS CUI [1,4])
Diabetes Mellitus
Item
history of diabetes
boolean
C0011849 (UMLS CUI [1])
Cerebrovascular accident | Transient Ischemic Attack | Myocardial Infarction
Item
history of stroke, transient ischemic attack or myocardial infarction.
boolean
C0038454 (UMLS CUI [1])
C0007787 (UMLS CUI [2])
C0027051 (UMLS CUI [3])
C0007787 (UMLS CUI [2])
C0027051 (UMLS CUI [3])
Weight Change Significant Quantity
Item
significant weight change > 10 lbs during screening period
boolean
C0005911 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0750502 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Diuretic
Item
patients taking a diuretic for 3 months prior to screening.
boolean
C0012798 (UMLS CUI [1])
Exclusion Criteria Study Protocol
Item
other protocol-defined exclusion criteria may apply.
boolean
C0680251 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])